Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells

Cell Biology International

Volumn 37, Issue 2, 2013, Pages 137-148

  Wang, Guoyan ^a   Zhang, Siying ^a   Wang, Feifei ^a   Li, Guangyun ^b   Zhang, Lixia ^a   Luan, Xiying ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Human; Mesenchymal stem cells; Placenta; Programmed death ligand

Indexed keywords

CD69 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2;

ARTICLE; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL CYCLE ARREST; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PLACENTA; PLACENTA MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD274; AUTOPHAGY; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMANS; LIGANDS; MESENCHYMAL STROMAL CELLS; PLACENTA; PREGNANCY; T-LYMPHOCYTE SUBSETS;

EID: 84874670758     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10024     Document Type: Article

References (35)

1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-22.
2. Allers C, Sierralta WD, Neubauer S, Rivera F, Minquell JJ, Conqet PA (2004) Dynamic of distribution of human bone marrowderived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78: 503-8.
3. Augello A, Tasso R,Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G (2005) Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35: 1482-90.
4. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-8.
5. Brooke G, Tong H, Levesque JP, Atkinson K (2008) Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cell Dev 17: 929-40.
6. Chang CJ, Yen M, Chen YC, Chien CC, Huang HI, Bai CH, Yen BL (2006) Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-g. Stem Cells 24: 2466-77.
7. Chen L, He DM, Zhang Y (2009) The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro. Cell Mol Biol Lett 14: 528-36.
8. Corcoran A, Mahon BP, McParland P, Davoren A, Doyle S (2003) Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women. J Med Virol 70: 475-80.
9. De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Waele M, Van Riet I (2007) Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92:440-9.
10. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-43.
11. Dong H, Zhu G, Tamada K, Chen L (1999) B7-H1, a thirdmember of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5: 1365-9.
12. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-74.
13. Hordijk P (2003) Endothelial signaling in leukocyte transmigration. Cell Biochem Biophys 38: 305-22.
14. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH (2006) Tissue expression of PDL1 mediates eripheral T cell tolerance. J Exp Med 203: 883-95.
15. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AL, Lazarus HM (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307-16.
16. Latchman Y, Wood CR, Chernova T, Chaudhary M, Chernoval I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno B (2001) PDL2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261-8.
17. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20.
18. Li G, Zhang XA, Wang H, Wang X, Meng CL, Chan CY, Yew DT, Tsang KS, Li K, Tsai SN, Ngai SM, Han ZC, Lin MC, He ML, Kung HF (2009) Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteormics 9: 20-30.
19. Loke P, Allison JP (2003) PDL1 and PDL2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci USA 100: 5336-41.
20. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30: 681-7.
21. MinWP, Gorczynski R, Huang XY, Kushida M, Kim P, Obataki M, Lei J, Suri RM, Cattral MS (2000) Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 164: 161-7.
22. -) thymocytes. Int Immunol 8: 773-80.
23. Nourshargh S, Marelli-Berg FM (2005) Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol 26: 157-65.
24. Pittenger MF,Mackay AM, Beck SC, Jaiswal RK, Douglas R,Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Mutilineage potential of adult human mesenchymal stem cells. Science 284: 143-7.
25. Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J (2007) The in vitro migration capacity of human bone marrowmesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-45.
26. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-50.
27. Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem cells 21: 105-10.
28. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, Shen B, Yin S, Liu W, Cui L, Li N (2008) A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res 18: 846-57.
29. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A (2006) Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24: 1254-64.
30. TseWT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-97.
31. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H (2001) B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193: 839-46.
32. Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364-70.
33. Xue Q, Luan XY, Gu YZ, Wu HY, Zhang GB, Yu GH, Zhu HT, Wang M, Dong W, Geng YJ, Zhang XG (2010) The negative co-signaling molecule B7H4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cell Dev 9: 27-38.
34. Yamazaki T, Akiba H, Iwai H (2002) Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169: 5538-45.
35. Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, Demetriou A, Wu GD (2006) The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24: 928-35.